StockWireNews
Tiny Float Alert: This Nasdaq Breakout Idea Recently Uplisted And Requires Full Attention Now
Full Report Arrives Tonight At 8:00PM EST Or Tomorrow At 9:30AM EST
Sign Up To My SMS Update System - Directions Below
October 11th
Greetings Readers,
The clock is ticking so let me get straight to it.
Tonight at 8:00PM EST or tomorrow at 9:30AM EST, I'll be bringing you a new Nasdaq breakout idea.
This comes on the heels of Monday's Nasdaq alert that surged from a Friday close of $.47 to a Monday high of $.56.
Making an approximately 19% quick run, it added nicely to last week's two Nasdaq profiles that ran approximately 18% and 38% (pre-market).
But that's the past. Let's look towards the future and what's next.
A recent Harvard study shared some pretty unsettling news.(1)
The medical cost of mental health conditions is estimated to rise to $6Tn by 2030.
And with the way the global news reads every day, mental health will definitely be something to watch closely in the years ahead.
One such market that has been growing significantly and gaining traction in the treatment of such issues and additional diseases is the psych-e-delics as treatment market.
Data Bridge Market Research analyses that the market is growing at such a rate that it could $8Bn by 2029.(2)
In other words, opportunities abound.
And one company I want to bring to your attention could be well-positioned to make a name for themselves in these growing markets.
Here's a few details I can share now ahead of the full report coming soon. Check them out:
3 Top Potential Catalysts - New Nasdaq Breakout Idea For Wednesday
#1. A tiny, tiny float. With Yahoo Finance reporting this profile to have a float fewer than 5Mn shares, volatility could crop up at a moment's notice.
#2. This is a newly uplisted Nasdaq company. Quite recently, this company uplisted to the Nasdaq and as time goes by this should help spread more awareness about what they are accomplishing.
#3. Big news this week. The company has already made a big announcement this week in regards to an important formulation study that could dramatically impact the company's standing in the pysch-e-delics field for years to come.
Take a moment and do this now: